The cannabis industry's rapid growth has sparked a pressing concern: its potential impact on mental health, particularly the risk of psychosis. Rami Hamati, a postdoctoral scholar, is at the forefront of this critical issue, delving into the biological pathways that link cannabis use to psychosis. With support from the Schulich Postdoctoral Fellowship Program, Hamati is exploring the role of the neurotransmitter dopamine in this complex relationship.
Hamati's journey into neuroscience began early, fueled by a fascination with the connection between substances and mental health during his teenage years working in his parents' pharmacy. This curiosity led him to pursue a master's degree in neuroscience, where he studied antidepressants' mechanisms in the brain using animal models. His PhD, also at the University of Ottawa, further solidified his expertise in neurotransmitters, particularly dopamine, through human neuroimaging techniques.
The postdoctoral fellowship provided by Schulich School of Medicine & Dentistry has enabled Hamati to join the lab of Jibran Khokhar, a professor in anatomy and cell biology, with co-supervision from Dr. Lena Palaniyappan. Together, they are investigating the causal role of dopamine in the interaction between cannabis and psychosis. Hamati's research aims to understand whether neuromelanin-sensitive MRI can predict patterns of cannabis use in individuals with psychosis and their ability to abstain.
The significance of Hamati's work extends beyond the lab. As an early-career scientist, he highlights the importance of sustained support for postdoctoral scholars, addressing the challenge of stagnant compensation in Canada. The Schulich Postdoctoral Fellowship Program, with its donor-matched funding, not only bridges the salary gap but also demonstrates the value of early-career researchers' contributions to the scientific community.
Hamati's enthusiasm for the research is palpable. He believes that understanding the link between the brain and the mind can reduce stigma and improve mental health outcomes. The interdisciplinary nature of his work, combining human studies and animal models, offers a comprehensive approach to unraveling the complex relationship between cannabis, dopamine, and psychosis.
In conclusion, Rami Hamati's research is a crucial step in understanding the biological underpinnings of cannabis-induced psychosis. His dedication to early-career scientists and the scientific community's support through fellowship programs are essential for advancing our knowledge and ultimately improving public health.
